The metastasis-associated molecule C4.4A promotes tissue invasion and anchorage independence by associating with the alpha6beta4 integrin

Molecular Oncology

Volumn 7, Issue 5, 2013, Pages 917-928

  Thuma, Florian ^a   Ngora, Honoré ^a   Zöller, Margot ^a,b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Alpha6beta4; C4.4A; Laminin 332; Metastasis; MMP14; PI3K Akt

Indexed keywords

ALPHA6BETA4 INTEGRIN; CISPLATIN; LAMININ RECEPTOR; LAMININ RECEPTOR C4 4A; MATRIX METALLOPROTEINASE 14; MATRIX PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAD; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER SURVIVAL; DRUG RESISTANCE; LUNG; LYMPH NODE; METASTASIS; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SURVIVAL TIME; TUMOR INVASION;

RATTUS;

ALPHA6BETA4; ASML-C4.4AKD; ASMLWT; BSP73ASML; C4.4A; C4.4A SHRNA TRANSFECTED ASML CELLS; CONCENTRATED SERUM-FREE AND VESICLE-DEPLETED CULTURE SUPERNATANT OF 804G CELLS; FORMERLY LAMININ 1 AND 5; GLYCOSYL-PHOSPHATIDYL INOSITOL; GPI; IMMUNOPRECIPITATION; IP; LAMININ 332; LN111/LN332; LN332; MEMBRANE TYPE 1 MATRIX METALLOPROTEINASE; METASTASIS; MMP-INH.II; MMP14; MMP9/13-INHIBITOR-II, WB: WESTERN BLOT; PI3K/AKT; Α6Β4; Α6Β4 INTEGRIN;

ANIMALS; APOPTOSIS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MOVEMENT; CISPLATIN; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GPI-LINKED PROTEINS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA6BETA4; LAMININ; MATRIX METALLOPROTEINASE 14; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS;

EID: 84884290676     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2013.05.002     Document Type: Article

References (56)

1. Bertotti A., Comoglio P.M., Trusolino L. Beta4 integrin is a transforming molecule that unleashes Met tyrosine kinase tumorigenesis. Cancer Res. 2005, 65:10674-10679.
2. Bon G., Folgiero V., Bossi G., Felicioni L., Marchetti A., Sacchi A., Falcioni R. Loss of beta4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivation. Clin. Cancer Res. 2006, 12:3280-3287.
3. Bon G., Folgiero V., Di Carlo S., Sacchi A., Falcioni R. Involvement of alpha6beta4 integrin in the mechanisms that regulate breast cancer progression. Breast Cancer Res. 2007, 9:203.
4. Borradori L., Sonnenberg A. Structure and function of hemidesmosomes: more than simple adhesion complexes. J.Invest. Dermatol. 1999, 112:411-418.
5. Claas C., Herrmann K., Matzku S., Möller P., Zöller M. Developmentally regulated expression of metastasis-associated antigens in the rat. Cell. Growth Differ. 1996, 7:663-678.
6. Danilkovitch-Miagkova A., Angeloni D., Skeel A., Donley S., Lerman M., Leonard E.J. Integrin-mediated RON growth factor receptor phosphorylation requires tyrosine kinase activity of both the receptor and c-Src. J.Biol. Chem. 2000, 275:14783-14786.
7. Decline F., Rousselle P. Keratinocyte migration requires alpha2beta1 integrin-mediated interaction with the laminin 5 gamma2 chain. J.Cell. Sci. 2001, 114:811-823.
8. de Pereda J.M., Ortega E., Alonso-García N., Gómez-Hernández M., Sonnenberg A. Advances and perspectives of the architecture of hemidesmosomes: lessons from structural biology. Cell. Adh. Migr. 2009, 3:361-364.
9. Fletcher G.C., Patel S., Tyson K., Adam P.J., Schenker M., Loader J.A., Daviet L., Legrain P., Parekh R., Harris A.L., Terrett J.A. hAG-2 and hAG-3 human homologues of genes involved in differentiation are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan. Br. J. Cancer 2003, 88:579-585.
10. Friedland J.C., Lakins J.N., Kazanietz M.G., Chernoff J., Boettiger D., Weaver V.M. alpha6beta4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF-kappaB-dependent resistance to apoptosis in 3D mammary acini. J.Cell. Sci. 2007, 120:3700-3712.
11. Fries F., Nazarenko I., Hess J., Claas A., Angel P., Zöller M. CEBPbeta, JunD and c-Jun contribute to the transcriptional activation of the metastasis-associated C4.4A gene. Int. J. Cancer 2007, 120:2135-2147.
12. Frijns E., Sachs N., Kreft M., Wilhelmsen K., Sonnenberg A. EGF-induced MAPK signaling inhibits hemidesmosome formation through phosphorylation of the integrin {beta}4. J.Biol. Chem. 2010, 285:37650-37662.
13. Giancotti F.G. Targeting integrin beta4 for cancer and anti-angiogenic therapy. Trends Pharmacol. Sci. 2007, 28:506-511.
14. Hansen L.V., Gardsvoll H., Nielsen B.S., Lund L.R., Dano K., Jensen O.N., Ploug M. Structural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptor. Biochem. J. 2004, 380:845-857.
15. Hansen L.V., Laerum O.D., Illemann M., Nielsen B.S., Ploug M. Altered expression of the urokinase receptor homologue, C4.4A, in invasive areas of human esophageal squamous cell carcinoma. Int. J. Cancer 2008, 122:734-741.
16. Hansen L.V., Skov B.G., Ploug M., Rappot H. Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer. Lung Cancer 2007, 58:260-266.
17. Hintermann E., Bilban M., Sharabi A., Quaranta V. Inhibitory role of alpha 6 beta 4-associated erbB-2 and phosphoinositide 3-kinase in keratinocyte haptotactic migration dependent on alpha 3 beta 1 integrin. J.Cell. Biol. 2001, 153:465-478.
18. Holmbeck K., Bianco P., Yamada S., Birkedal-Hansen H. MT1-MMP: a tethered collagenase. J.Cell. Physiol. 2004, 200:11-19.
19. Homma Y., Ozono S., Numata I., Seidenfeld J., Oyasu R. alpha-Difluoromethylornithine inhibits cell growth stimulated by a tumor-promoting rat urinary fraction. Carcinogenesis 1985, 6:159-161.
20. Jacobsen B., Ploug M. The urokinase receptor and its structural homologue C4.4A in human cancer: expression, prognosis and pharmacological inhibition. Curr. Med. Chem. 2008, 15:2559-2573.
21. Jacobsen B., Santoni-Rugiu E., Illemann M., Kriegbaum M.C., Laerum O.D., Ploug M. Expression of C4.4A in precursor lesions of pulmonary adenocarcinoma and squamous cell carcinoma. Int. J. Cancer 2012, 130:2734-2739.
22. Jung T., Gross W., Zöller M. CD44v6 coordinates tumor matrix-triggered motility and apoptosis resistance. J.Biol. Chem. 2011, 286:15862-15874.
23. Kariya Y., Kariya Y., Gu J. Roles of laminin-332 and alpha6beta4 integrin in tumor progression. Mini. Rev. Med. Chem. 2009, 9:1284-1291.
24. Klingbeil P., Marhaba R., Jung T., Kirmse R., Ludwig T., Zöller M. CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance. Mol. Cancer Res. 2009, 7:168-179.
25. Konishi K., Yamamoto H., Mimori K., Takemasa I., Mizushima T., Ikeda M., Sekimoto M., Matsuura N., Takao T., Doki Y., Mori M. Expression of C4.4A at the invasive front is a novel prognostic marker for disease recurrence of colorectal cancer. Cancer Sci. 2010, 101:2269-2277.
26. Koshikawa N., Minegishi T., Sharabi A., Quaranta V., Seiki M. Membrane-type matrix metalloproteinase-1 (MT1-MMP) is a processing enzyme for human laminin gamma 2 chain. J.Biol. Chem. 2005, 280:88-93.
27. Kriegbaum M.C., Jacobsen B., Hald A., Ploug M. Expression of C4.4A, a structural uPAR homolog, reflects squamous epithelial differentiation in the adult mouse and during embryogenesis. J.Histochem. Cytochem. 2011, 59:188-201.
28. Lipscomb E.A., Mercurio A.M. Mobilization and activation of a signaling competent alpha6beta4integrin underlies its contribution to carcinoma progression. Cancer Metastasis Rev. 2005, 24:413-423.
29. Marinkovich M.P. Tumour microenvironment: laminin 332 in squamous-cell carcinoma. Nat. Rev. Cancer 2007, 7:370-380.
30. Matzku S., Komitowski D., Mildenberger M., Zöller M. Characterization of BSp73 a spontaneous rat tumor and its invivo selected variants showing different metastasizing capacities. Invasion Metastasis 1983, 3:109-123.
31. Mercurio A.M., Rabinovitz I. Towards a mechanistic understanding of tumor invasion-lessons from the alpha6beta 4 integrin. Semin. Cancer Biol. 2001, 11:129-141.
32. Merdek K.D., Yang X., Taglienti C.A., Shaw L.M., Mercurio A.M. Intrinsic signaling functions of the beta4 integrin intracellular domain. J.Biol. Chem. 2007, 282:30322-30330.
33. Mina L.A., Sledge G.W. Rethinking the metastatic cascade as a therapeutic target. Nat. Rev. Clin. Oncol. 2011, 8:325-332.
34. Ngora H., Galli U.M., Miyazaki K., Zöller M. Membrane-bound and exosomal metastasis-associated C4.4A promotes migration by associating with the ?(6)?(4) integrin and MT1-MMP. Neoplasia 2012, 14:95-107.
35. Nguyen B.P., Ryan M.C., Gil S.G., Carter W.G. Deposition of laminin 5 in epidermal wounds regulates integrin signaling and adhesion. Curr. Opin. Cell. Biol. 2000, 12:554-562.
36. Oku N., Sasabe E., Ueta E., Yamamoto T., Osaki T. Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1. Cancer Res. 2006, 66:5251-5257.
37. Paret C., Bourouba M., Beer A., Miyazaki K., Schnölzer M., Fiedler S., Zöller M. Ly6 family member C4.4A binds laminins 1 and 5 associates with galectin-3 and supports cell migration. Int. J. Cancer 2005, 115:724-733.
38. Paret C., Hildebrand D., Weitz J., Kopp-Schneider A., Kuhn A., Beer A., Hautmann R., Zöller M. C4.4A as a candidate marker in the diagnosis of colorectal cancer. Br. J. Cancer 2007, 97:1146-1156.
39. Pullar C.E., Baier B.S., Kariya Y., Russell A.J., Horst B.A., Marinkovich M.P., Isseroff R.R. beta4 integrin and epidermal growth factor coordinately regulate electric field-mediated directional migration via Rac1. Mol. Biol. Cell. 2006, 17:4925-4935.
40. Rösel M., Claas C., Seiter S., Herlevsen M., Zöller M. Cloning and functional characterization of a new phosphatidyl-inositol anchored molecule of a metastasizing rat pancreatic tumor. Oncogene 1998, 17:1989-2002.
41. Sehgal B.U., DeBiase P.J., Matzno S., Chew T.L., Claiborne J.N., Hopkinson S.B., Russell A., Marinkovich M.P., Jones J.C. Integrin beta4 regulates migratory behavior of keratinocytes by determining laminin-332 organization. J.Biol. Chem. 2006, 281:35487-35498.
42. Seiter S., Stassar M., Rappl G., Reinhold U., Tilgen W., Zöller M. Upregulation of C4.4A expression during progression of melanoma. J.Invest. Dermatol. 2001, 116:344-347.
43. Shaw L.M. Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha6beta4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion. Mol. Cell. Biol. 2001, 21:5082-5093.
44. Smith B.A., Kennedy W.J., Harnden P., Selby P.J., Trejdosiewicz L.K., Southgate J. Identification of genes involved in human urothelial cell-matrix interactions: implications for the progression pathways of malignant urothelium. Cancer Res. 2001, 61:1678-1685.
45. Staubach S., Hanisch F.G. Lipid rafts: signaling and sorting platforms of cells and their roles in cancer. Expert Rev. Proteom. 2011, 8:263-277.
46. Strasser A., Cory S., Adams J.M. Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J. 2011, 30:3667-3683.
47. Streuli C.H., Akhtar N. Signal co-operation between integrins and other receptor systems. Biochem. J. 2009, 418:491-506.
48. Trusolino L., Bertotti A., Comoglio P.M. A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth. Cell 2001, 107:643-654.
49. Udayakumar T.S., Chen M.L., Bair E.L., VonBredow D.C., Cress A.E., Nagle R.B. Bowden GT. Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 beta3 chain and induces cell migration. Cancer Res. 2003, 63:2292-2299.
50. Wang W., Ding Y.Q., Li Z.G., Han H.X., Yang L. Expression and diagnostic application of C4.4A protein in squamous cell carcinoma and adenocarcinoma. Zhonghua Bing Li Xue Za Zhi 2006, 35:277-280.
51. Wilhelmsen K., Litjens S.H., Sonnenberg A. Multiple functions of the integrin alpha6beta4 in epidermal homeostasis and tumorigenesis. Mol. Cell. Biol. 2006, 26:2877-2886.
52. Würfel J., Rösel M., Seiter S., Claas C., Herlevsen M., Weth R., Zöller M. Cloning of the human homologue of the metastasis-associated rat C4.4A. Gene 2001, 262:35-41.
53. Yañez-Mó M., Barreiro O., Gonzalo P., Batista A., Megías D., Genís L., Sachs N., Sala-Valdés M., Alonso M.A., Montoya M.C., Sonnenberg A., Arroyo A.G., Sánchez-Madrid F. MT1-MMP collagenolytic activity is regulated through association with tetraspanin CD151 in primary endothelial cells. Blood 2008, 112:3217-3226.
54. Yang X., Dutta U., Shaw L.M. SHP2 mediates the localized activation of Fyn downstream of the α6β4 integrin to promote carcinoma invasion. Mol. Cell. Biol. 2010, 30:5306-5317.
55. Yang X., Kovalenko O.V., Tang W., Claas C., Stipp C.S., Hemler M.E. Palmitoylation supports assembly and function of integrin-tetraspanin complexes. J.Cell. Biol. 2004, 167:1231-1240.
56. Zahnow C.A. CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases. Expert Rev. Mol. Med. 2009, 11:e12.